3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
9
Prostatic Neoplasms
9
Glioma
9
Osteosarcoma
8
Neuroblastoma
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Rhabdoid Tumor
7
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Lung Neoplasms
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Central Nervous System Neoplasms
5
Carcinoma, Hepatocellular
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Interventions
pembrolizumab
22
Nivolumab
14
enfortumab vedotin
13
Gemcitabine
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cisplatin
8
Carboplatin
8
sacituzumab govitecan
6
avelumab
6
Docetaxel
6
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
X-Rays
×
90 days
×
Clear all
No trials found.